Sunshine Biopharma, Inc (CIK: 0001402328) EDGAR, Information, Filings... CompaniesBIO.Com

Sunshine Biopharma, Inc

Mailing address
6500 TRANS-CANADA HIGHWAY, 4TH FLOOR, POINTE-CLAIRE, Colorado, H9R 0A5
Phone
514-426-6161
State location
A8
State of incorporation
Colorado
Fiscal year end
December 31
SIC
8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Filings
N/A

Sunshine Biopharma, Inc (CIK: 0001402328) is an American company incorporated in the state of A8. Head office is located at 6500 TRANS-CANADA HIGHWAY, 4TH FLOOR, POINTE-CLAIRE, A8, H9R 0A5. Work in the industry 8731 - (CF Office: Office of Trade & Services) SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH. Sunshine Biopharma, Inc is a public company and trade via Over-The-Counter (OTC).

Old names:

Mountain West Business Solutions, Inc from 2007-05-Nov to 2009-02-Nov
mountain west business solutions,inc from 2007-19-Oct to 2007-19-Oct
mountain state business solutions,inc from 2007-25-May to 2007-25-May

Owner	Filings	Transaction Date	Type of Owner
Chamoun Malek	0001951769	Oct-20-2022	10 percent owner
NATAN DAVID	0001253108	Feb-10-2022	director
Keller Andrew Mark	0001909593	Feb-10-2022	director
TELSEY ANDREW I	0001103152	Oct-31-2021	director
Kish James Daniel	0001895995	Oct-31-2021	director
Kiderchah Rabi	0001896715	Oct-31-2021	director
Advanomics Corp	0001681176	Jul-08-2016	10 percent owner
MERZOUKI ABDERRAZZAK	0001636418	Feb-20-2015	director, officer: Chief Operating Officer
Slilaty Steve N.	0001474684	Oct-15-2009	director, 10 percent owner, officer: CEO and President
Sebaaly Camille	0001474695	Oct-15-2009	director, officer: CFO and Secretary
Di Turi Michele	0001474699	Oct-15-2009	director, officer: Chief Operating Officer

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Sunshine Biopharma, Inc

Filings	Format	Description	Filed/Effective	File/Film Number
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001683168-24-005846 (34 Act) Size: 3917 KB	Aug-16-2024	001-41282 241217406
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001683168-24-005691 (34 Act) Size: 22 KB	Aug-14-2024	001-41282 241207461
8-K	Document	Current report filing Acc-no: 0001683168-24-005496 (34 Act) Size: 252 KB	Aug-12-2024	001-41282 241196715
DEF 14C	Document	Definitive information statements Acc-no: 0001683168-24-004755 (34 Act) Size: 70 KB	Jul-11-2024	001-41282 241112035
8-K	Document	Current report filing Acc-no: 0001683168-24-004601 (34 Act) Size: 236 KB	Jul-02-2024	001-41282 241095116
PRE 14C	Document	Preliminary information statement not related to a contested matter or merger/acquisition Acc-no: 0001683168-24-004574 (34 Act) Size: 70 KB	Jul-01-2024	001-41282 241091147
8-K	Document	Current report filing Acc-no: 0001683168-24-004572 (34 Act) Size: 236 KB	Jul-01-2024	001-41282 241090510
8-K	Document	Current report filing Acc-no: 0001683168-24-004120 (34 Act) Size: 235 KB	Jun-11-2024	001-41282 241035689
8-K	Document	Current report filing Acc-no: 0001683168-24-004053 (34 Act) Size: 241 KB	Jun-07-2024	001-41282 241029152
8-K	Document	Current report filing Acc-no: 0001683168-24-003777 (34 Act) Size: 265 KB	May-22-2024	001-41282 24973346
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001683168-24-003688 (34 Act) Size: 3630 KB	May-20-2024	001-41282 24964121
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001683168-24-003460 (34 Act) Size: 21 KB	May-15-2024	001-41282 24948100
8-K	Document	Current report filing Acc-no: 0001683168-24-003104 (34 Act) Size: 237 KB	May-08-2024	001-41282 24926514
8-K	Document	Current report filing Acc-no: 0001683168-24-003004 (34 Act) Size: 268 KB	May-06-2024	001-41282 24916526
8-K	Document	Current report filing Acc-no: 0001683168-24-002616 (34 Act) Size: 505 KB	Apr-23-2024	001-41282 24864832
8-K	Document	Current report filing Acc-no: 0001683168-24-001993 (34 Act) Size: 263 KB	Apr-01-2024	001-41282 24808233
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001683168-24-001818 (34 Act) Size: 4919 KB	Mar-28-2024	001-41282 24798799
DEF 14C	Document	Definitive information statements Acc-no: 0001683168-24-001487 (34 Act) Size: 73 KB	Mar-15-2024	001-41282 24753104
8-K	Document	Current report filing Acc-no: 0001683168-24-001357 (34 Act) Size: 238 KB	Mar-06-2024	001-41282 24725862
PRE 14C	Document	Preliminary information statement not related to a contested matter or merger/acquisition Acc-no: 0001683168-24-001323 (34 Act) Size: 73 KB	Mar-05-2024	001-41282 24721316

Recent 20 filings. View all Sunshine Biopharma, Inc filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Sunshine Biopharma, Inc overview
Sunshine Biopharma, Inc job
Sunshine Biopharma, Inc stock
Sunshine Biopharma, Inc ownership
Sunshine Biopharma, Inc CEO
Sunshine Biopharma, Inc documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.